Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 3Thoracic 2Other hematologic neoplasm 2Lymphoid 2Tumor-Agnostic 1Head & Neck 1Dermatologic 1CNS 1Breast 1

Conditions

Uveal Melanoma 1Triple Negative Breast Neoplasms 1Neoplasm Metastasis 1Melanoma 1Lung Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 547Pemetrexed 402Cisplatin 400Paclitaxel 272Docetaxel 255Gemcitabine 218pembrolizumab 190Bevacizumab 190Erlotinib Hydrochloride 184Radiotherapy 179Etoposide 147durvalumab 140Nivolumab 134Drug Therapy 127osimertinib 106atezolizumab 92Gefitinib 74Radiosurgery 71anlotinib 69Vinorelbine 68tislelizumab 52Irinotecan 51Ipilimumab 50130-nm albumin-bound paclitaxel 49Taxes 48Surgical Procedures, Operative 46Cetuximab 46sintilimab 45Albumin-Bound Paclitaxel 45apatinib 44

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Valacyclovir × Thoracic × Clear all
NCT03004183 2024-10-15

STOMP

The Methodist Hospital Research Institute

Phase 2 Completed
57 enrolled 12 charts
BreastThoracic

Carcinoma, Non-Small-Cell Lung, Triple Negative Breast Neoplasms

NCT02831933 2023-09-21

ENSIGN

The Methodist Hospital Research Institute

Phase 2 Terminated
11 enrolled 9 charts
DermatologicThoracic

Uveal Melanoma, Lung Neoplasms, Melanoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡